Online citations, reference lists, and bibliographies.

Formulation, Optimization And Characterization Of Cationic Polymeric Nanoparticles Of Mast Cell Stabilizing Agent Using The Box–Behnken Experimental Design

Balaram Gajra, Ravi R. Patel, Chintan A Dalwadi
Published 2016 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Objective: The present research work was intended to develop and optimize sustained release of biodegradable chitosan nanoparticles (CSNPs) as delivery vehicle for sodium cromoglicate (SCG) using the circumscribed Box–Behnken experimental design (BBD) and evaluate its potential for oral permeability enhancement. Methods: The 3-factor, 3-level BBD was employed to investigate the combined influence of formulation variables on particle size and entrapment efficiency (%EE) of SCG-CSNPs prepared by ionic gelation method. The generated polynomial equation was validated and desirability function was utilized for optimization. Optimized SCG-CSNPs were evaluated for physicochemical, morphological, in-vitro characterizations and permeability enhancement potential by ex-vivo and uptake study using CLSM. Results: SCG-CSNPs exhibited particle size of 200.4 ± 4.06 nm and %EE of 62.68 ± 2.4% with unimodal size distribution having cationic, spherical, smooth surface. Physicochemical and in-vitro characterization revealed existence of SCG in amorphous form inside CSNPs without interaction and showed sustained release profile. Ex-vivo and uptake study showed the permeability enhancement potential of CSNPs. Conclusions: The developed SCG-CSNPs can be considered as promising delivery strategy with respect to improved permeability and sustained drug release, proving importance of CSNPs as potential oral delivery system for treatment of allergic rhinitis. Hence, further studies should be performed for establishing the pharmacokinetic potential of the CSNPs.
This paper references
10.5860/choice.44-5373
The Merck index : an encyclopedia of chemicals, drugs, and biologicals
S. Budavari (1983)
10.1201/9780849374555
Nanoparticle technology for drug delivery
R. B. Gupta (2006)
PREPARATION AND CHARACTERIZATION OF IONOTROPIC CROSS-LINKED CHITOSAN MICROPARTICLES FOR CONTROLLED RELEASE OF ACECLOFENAC
N. G. Raghavendra Rao (2010)
10.1080/00401706.1960.10489912
Some New Three Level Designs for the Study of Quantitative Variables
G. P. Box (1960)
10.1517/17425247.2014.917076
Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis
P. Chaubey (2014)
Curcuminloaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery
NS Rejinold (2011)
10.1166/ASL.2014.5473
Investigation of Critical Variables of Core–Shell Polymer Lipid Hybrid Nanoparticles by Using Plackett-Burman Screening Design
Ravi R. Patel (2014)
(III) Particle size and drug content (%) of SCG-CSNPs at different time interval and in different environmental conditions during stability study
10.1023/A:1012160102740
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
N. G. Schipper (2004)
10.1016/J.CARBPOL.2011.01.044
The effect of prolonged storage at different temperatures on the particle size distribution of tripolyphosphate (TPP)-chitosan nanoparticles
Gordon A Morris (2011)
10.1007/s11095-004-7671-9
Oral Absorption Enhancement of Cromolyn Sodium Through Noncovalent Complexation
Xuan Ding (2004)
10.1016/j.colsurfb.2011.09.042
Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
W. Fan (2012)
10.1208/pt0804086
Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-behnken design
Ajay B. Solanki (2008)
10.1016/j.ejps.2009.04.008
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
Robhash Kusam Subedi (2009)
10.1007/s11095-007-9367-4
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
B. Sarmento (2007)
10.1016/S0378-5173(02)00487-8
Preparation and characterization of chitosan microparticles intended for controlled drug delivery.
J. A. Ko (2002)
10.1016/j.ijpharm.2011.04.003
Facilitated nanoscale delivery of insulin across intestinal membrane models.
Camile B. Woitiski (2011)
10.1007/BF03189357
An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine
L. Barthe (2010)
10.1166/ASL.2014.5478
Optimization of Parameters for the Fabrication of Curcumin Loaded Polymeric Nanoparticles Using Taguchi Robust Design
Sundeep Chaurasia (2014)
10.1016/j.ejps.2011.06.007
Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.
Jianing Meng (2011)
10.1016/j.colsurfb.2009.11.007
Encapsulation of ascorbyl palmitate in chitosan nanoparticles by oil-in-water emulsion and ionic gelation processes.
R. Yoksan (2010)
10.1016/j.nano.2009.04.001
Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine.
B. Wilson (2010)
Martindale : the complete drug reference
Alison Brayfield (2014)
10.1021/CM901259N
Synthesis and Characterization of Biocompatible and Size-Tunable Multifunctional Porous Silica Nanoparticles
Y. S. Lin (2009)
10.1186/s40199-014-0087-0
Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design
B. Gajra (2014)
10.1016/j.ijpharm.2010.11.040
Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.
L. Nolan (2011)
Formulation and characterization of clarithromycin based nanoparticulate drug delivery system
Rajkumari Thagele (2011)
Allergic rhinitis and co-morbidities training module
T U Sukumaran (2011)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1007/BF03218428
A kinetic study of thermal degradations of chitosan/polycaprolactam blends
S. K. Liao (2004)
10.1080/107175400455173
Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori.
J. Wang (2000)
10.1007/S13312-011-0091-0
Allergic rhinitis and co-morbidities training module (ARCTM)
T. U. Sukumaran (2011)
10.1023/A:1020404615898
Uptake of FITC-Chitosan Nanoparticles by A549 Cells
M. Huang (2004)
10.1016/S0169-409X(00)00118-6
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
R. Mueller (2001)
10.1016/S1000-1948(11)60054-3
Effects of chitosan-TPP nanoparticles on hepatic tissue after severe bleeding
Aiyuan Zhao (2011)
10.4314/TJPR.V9I5.61061
Formulation and Evaluation of Chitosan-Based Ampicillin Trihydrate Nanoparticles
Partha Saha (2010)
10.1016/j.ijpharm.2010.09.012
Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting.
Swati A. Guhagarkar (2010)
10.1007/s11095-007-9438-6
Mechanistic Understanding of Oral Drug Absorption Enhancement of Cromolyn Sodium by an Amino Acid Derivative
Adam W. G. Alani (2007)
10.1016/j.nano.2009.04.007
Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method.
M. R. Avadi (2010)
10.1166/ASL.2014.5483
Development and Optimization of Atorvastatin Calcium Loaded Oral Biodegradable Polymeric Nanoparticles Using Central Composite Design
Nagendra Kumar (2014)
10.1016/j.jcis.2011.04.006
Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery.
N. S. Rejinold (2011)
Martindale the complete drug
S. Sweetman (2005)
10.5402/2011/246162
Preparation and Characterisation of Highly Loaded Fluorescent Chitosan Nanoparticles
Haliza Katas (2011)
Preparation and Characterization of Rivastigmine Loaded Chitosan Nanoparticles
Simar preet Kaur (2011)
10.1016/j.carbpol.2015.04.062
Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.
Sundeep Chaurasia (2015)



This paper is referenced by
10.1080/21691401.2016.1247850
Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation
Manmohan Singh Jangdey (2017)
10.1080/03639045.2018.1546315
The efficacy of anti-VEGF antibody-modified liposomes loaded with paeonol in the prevention and treatment of hypertrophic scars
J. Shi (2019)
10.1371/journal.pone.0227231
An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect
M. A. Hamdi (2020)
10.1016/j.ijpharm.2017.09.061
Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications.
Nayab Tahir (2017)
10.1016/j.ejps.2019.02.015
Cromolyn‐crosslinked chitosan nanoparticles for the treatment of allergic rhinitis
Angela Abruzzo (2019)
10.1016/j.ijbiomac.2015.11.084
Cromolyn sodium encapsulated PLGA nanoparticles: An attempt to improve intestinal permeation.
Ravi R. Patel (2016)
10.1016/J.JDDST.2019.05.026
Rapamycin-loaded polysorbate 80-coated PLGA nanoparticles: Optimization of formulation variables and in vitro anti-glioma assessment
Oscar Escalona-Rayo (2019)
10.3109/03639045.2016.1168599
Nanoparticles and nanosuspensions: physical and biological properties
H. Smyth (2016)
10.1016/j.jddst.2019.101337
Rational design and in-vivo estimation of Ivabradine Hydrochloride loaded nanoparticles for management of stable angina
Vipin Sharma (2019)
10.1016/j.xphs.2016.09.014
Pharmaceutical Amorphous Nanoparticles.
Rajan Jog (2017)
10.3109/02652048.2016.1144819
Highly water-soluble mast cell stabiliser-encapsulated solid lipid nanoparticles with enhanced oral bioavailability
Ravi R. Patel (2016)
10.3109/21691401.2016.1163714
Exemestane encapsulated vitamin E-TPGS–polymeric nanoparticles: preparation, optimization, characterization, and in vitro cytotoxicity assessment
B. Mishra (2017)
Semantic Scholar Logo Some data provided by SemanticScholar